WallStreetZenWallStreetZen

NASDAQ: VRCA
Verrica Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VRCA past revenue growth

How has VRCA's revenue growth performed historically?
Company
-43.27%
Industry
149.51%
Market
17.15%
VRCA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VRCA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

VRCA earnings and revenue history

Current Revenue
$5.1M
Current Earnings
-$67.0M
Current Profit Margin
-1,307.5%

VRCA Return on Equity

Current Company
-147%
Current Industry
-63.5%
Current Market
188%
VRCA's Return on Equity (-147%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VRCA announces earnings.

VRCA Return on Assets

Current Company
-86.6%
Current Industry
2.9%
VRCA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VRCA Return on Capital Employed

Current Company
-97.62%
Current Industry
19.5%
VRCA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VRCA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VRCA$5.12M-$62.20M-$67.00M-34.65%N/A
XOMA$4.76M-$39.24M-$46.30M-2.13%N/A
TERN$0.00-$89.09M-$90.21M-100.00%N/A
VNDA$192.64M$9.35M$2.51M-0.05%-39.66%
GLUE$0.00-$128.79M-$135.35MN/AN/A
View Top Biotech Stocks

VRCA earnings dates

Next earnings date
May 7, 2024

Verrica Pharmaceuticals Earnings & Revenue FAQ

What were VRCA's earnings last quarter?

On Invalid Date, Verrica Pharmaceuticals (NASDAQ: VRCA) reported Q4 2023 earnings per share (EPS) of -$0.54, up 285.71% year over year. Total Verrica Pharmaceuticals earnings for the quarter were -$24.61 million. In the same quarter last year, Verrica Pharmaceuticals's earnings per share (EPS) was -$0.14.

If you're new to stock investing, here's how to buy Verrica Pharmaceuticals stock.

What was VRCA's earnings growth in the past year?

As of Q2 2024, Verrica Pharmaceuticals's earnings has grown year over year. Verrica Pharmaceuticals's earnings in the past year totalled -$67.00 million.

What is VRCA's earnings date?

Verrica Pharmaceuticals's earnings date is Invalid Date. Add VRCA to your watchlist to be reminded of VRCA's next earnings announcement.

What was VRCA's revenue last quarter?

On Invalid Date, Verrica Pharmaceuticals (NASDAQ: VRCA) reported Q4 2023 revenue of $1.99 million up 2,823.53% year over year. In the same quarter last year, Verrica Pharmaceuticals's revenue was $68.00 thousand.

What was VRCA's revenue growth in the past year?

As of Q2 2024, Verrica Pharmaceuticals's revenue has grown -43.27% year over year. This is 192.78 percentage points lower than the US Biotechnology industry revenue growth rate of 149.51%. Verrica Pharmaceuticals's revenue in the past year totalled $5.12 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.